In vitro and in vivo evaluation of a technetium-99m-labeled 2-nitroimidazole (BMS181321) as a marker of tumor hypoxia.
Year: 1996
Type: article
Source: PubMed
Authors: J R Ballinger, J W Kee, A M Rauth
Institution: Princess Margaret Cancer Centre
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2256308302
